MGNX - Latest News

MacroGenics, Inc. (MGNX), operates in Healthcare / Biotechnology, trades on NASDAQ.

Market capitalization stands near $268.2M. Beta to the broader market is 1.22.

The article list below shows the most recent MGNX headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent MGNX Headlines

Gilead Sciences Has Quietly Become One of the Most Underrated Turnaround Stories in Healthcare. Here's Why Wall Street Is Excited.

fool.com - Aug 18, 2026

The company's HIV franchise is stronger than ever, and it's adding a stable of oncology drugs.

MacroGenics (MGNX) Reports Q2 Loss, Lags Revenue Estimates

zacks.com - Aug 13, 2026

MacroGenics (MGNX) came out with a quarterly loss of $0. 27 per share versus the Zacks Consensus Estimate of a loss of $0.

MacroGenics Reports Second Quarter 2026 Financial Results, Streamlined Operating Model and Strengthened Financial Position

globenewswire.com - Aug 13, 2026

ROCKVILLE, Md. , Aug.

MacroGenics Announces Achievement of $10 Million Milestone Following Gilead's Exercise of Option to License Preclinical Bispecific Program

globenewswire.com - Aug 11, 2026

ROCKVILLE, MD, Aug. 11, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc.

MacroGenics, Inc. (NASDAQ:MGNX) Given Consensus Rating of “Hold” by Brokerages

defenseworld.net - Aug 3, 2026

Shares of MacroGenics, Inc. (NASDAQ: MGNX - Get Free Report) have been given an average rating of "Hold" by the seven ratings firms that are covering

How News Affects MGNX Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track MGNX's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked MGNX news questions

What is the latest MGNX news headline?

The most recent MGNX headline (Aug 18, 2026) is "Gilead Sciences Has Quietly Become One of the Most Underrated Turnaround Stories in Healthcare. Here's Why Wall Street Is Excited.". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the MGNX news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What MGNX news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual MGNX options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.